Currently out of the existing stock ratings of Steven Frankel, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).

Steven Frankel

Work Performance Price Targets & Ratings Chart

Analyst Steven Frankel works at ROSENBLATT with a stock forecast success ratio of 57.89% fulfilled within 518.33 days on average.

Steven Frankel’s has documented 111 price targets and ratings displayed on 9 stocks. The coverage is on Communication Services, Technology, Consumer Defensive sectors.

Most recent stock forecast was given on XPER, Xperi Corp at 01-Mar-2024.

Wall Street Analyst Steven Frankel

Analyst best performing recommendations are on QUOT (QUOTIENT TECHNOLOGY).
The best stock recommendation documented was for QUOT (QUOTIENT TECHNOLOGY) at 9/9/2022. The price target of $3 was fulfilled within 61 days with a profit of $1.1 (57.89%) receiving and performance score of 9.49.

Average potential price target upside

AVID Avid Technology DLB Dolby Laboratories QUOT Quotient Technology SEAC SeaChange International HLIT Harmonic UEIC Universal Electronics UTI Universal Technical Institute BCOV Brightcove XPER Xperi Corp

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

27.05

$0.01 (0.04%)

45

8 months 9 days ago

0/2 (0%)

$0.48 (1.81%)

Hold

27.05

$0.01 (0.04%)

34

8 months 14 days ago

8/11 (72.73%)

$0.39 (1.46%)

85

Hold

30

$5.51 (22.50%)

1 years 9 months 12 days ago

2/3 (66.67%)

$2.19 (11.34%)

1106

Hold

30

$2.96 (10.95%)

33

1 years 11 months 1 days ago

7/7 (100%)

$3.9 (14.94%)

47

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Steven Frankel is most bullish on?

Potential upside of $4.25 has been obtained for XPER (XPERI CORP)

What Year was the first public recommendation made by Steven Frankel?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?